Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Oragenics, Inc. (OGEN : AMEX)

• Company Description    Oragenics Inc is a biotechnology company focused on the development and licensure of innovative products and technologies for improving human health. Number of Employees: 6

• Price / Volume Information    Yesterday's Closing Price: $0.51 Daily Weekly Monthly 20 Day Moving Average: 29,188 shares Shares Outstanding: 4.51 (millions) Market Capitalization: $2.31 (millions) Beta: 1.25 52 Week High: $1.46 52 Week Low: $0.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -10.74% -11.40% 12 Week -14.00% -16.36% Year To Date -34.75% -40.41%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9015 TOWN CENTER PARKWAY SUITE 143 - LAKEWOOD RANCH,FL 34202 USA ph: 813-286-7900 fax: 813-286-7904 ir@oragenics.com http://www.oragenics.com

• General Corporate Information    Officers Janet Huffman - Chief Executive Officer & Chief Financial Officer Robert C. Koski - Director Charles L. Pope - Director Frederick W. Telling - Director Alan W. Dunton - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 684023609 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/14/26 Share - Related Items Shares Outstanding: 4.51 Most Recent Split Date: 6.00 (0.03:1) Beta: 1.25 Market Capitalization: $2.31 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/14/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.36 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 85.85% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/26 - - 03/31/26 - -177.32 12/31/25 - -244.19 ROA 06/30/26 - - 03/31/26 - -121.29 12/31/25 - -136.77 Current Ratio 06/30/26 - - 03/31/26 - 5.73 12/31/25 - 5.64 Quick Ratio 06/30/26 - - 03/31/26 - 5.73 12/31/25 - 5.64 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Book Value 06/30/26 - - 03/31/26 - 1.43 12/31/25 - 1.94 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©